Stocks and Investing
Stocks and Investing
Tue, January 2, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, December 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, December 28, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Oren Livnat Maintained (zvra) at Strong Buy with Increased Target to $15 on, Dec 28th, 2023
Oren Livnat of HC Wainwright & Co., Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Increased Target from $10 to $15 on, Dec 28th, 2023.
Oren has made no other calls on ZVRA in the last 4 months.
There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Oren's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Oren
- Jonathan Aschoff of "Roth MKM" Reiterated at Strong Buy and Held Target at $25 on, Friday, October 6th, 2023
- Sumant Kulkarni of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $20 on, Friday, September 1st, 2023
Contributing Sources